Overview

When a child or teenager says they are trans, many families are soon dealing with a gender clinic, a specialist therapist or an endocrinologist (a doctor who specialises in hormones). This page is a practical guide to that world. It explains how youth gender services are organised in different countries, how the main clinical models differ, which questions parents can ask, and what families and detransitioners report about their own clinics, both good and bad.

This page is not medical advice. It does not tell you whether any treatment is right for your child. It aims to help you ask better questions and understand the answers. For the first conversations at home, see When a Child Says They Are Trans. For the evidence on specific treatments, see Medical Transition and Evidence Reviews.

How youth gender services work in different countries

United Kingdom

For decades, under-18s in England and Wales were seen by one national service, the Gender Identity Development Service (GIDS) at the Tavistock and Portman NHS Foundation Trust in London. After the Cass Review, an independent review led by paediatrician Dr Hilary Cass, found that the service had been running on a "remarkably weak" evidence base, GIDS closed in March 2024 (Cass 2024). It was replaced by regional NHS Children and Young People's Gender Services, run by children's hospitals. The first two opened in April 2024: one led by Great Ormond Street Hospital in London, and a North West service run by Alder Hey and Royal Manchester Children's Hospital (Alder Hey). The Cass Review wanted these centres to have strong links to mental health services and to assess the whole child, including screening for autism and other conditions.

Since then, treatment options have narrowed sharply:

• Puberty blockers (drugs that pause puberty) stopped being routinely prescribed in March 2024, and a ban on new prescriptions outside research was later made indefinite (BBC 2025). The only remaining route is the PATHWAYS trial, a King's College London study of about 220 children. Regulators paused it in February 2026 and agreed new protocols in June. The High Court rejected a legal challenge on 31 July 2026, and recruitment began in August (Independent 2026). See Puberty Blockers.
• Cross-sex hormones for 16- and 17-year-olds: NHS England paused new prescriptions in March 2026 after a review found the research "really weak", and opened a consultation on ending them as a routine treatment (BBC 2026).
• Waiting lists are long. By March 2025, 6,225 children were on the national waiting list for England and Wales, and the average wait for a first appointment was over two years (Independent 2025). Adult clinics, which take young people from 17, were found by the Levy review (an NHS England review of adult gender clinics, December 2025) to have waits of over five years and poor safety monitoring (BMJ 2025).

The long waits matter to parents in two ways. Some families use the time for therapy and support. Others are approached by private online providers that prescribe without NHS assessment. One of these, GenderGP, is covered on GenderGP. For the law, see United Kingdom.

United States

The US has no national system. Youth gender care grew up in hospital-based "gender-affirming" clinics, often following guidelines from the World Professional Association for Transgender Health (WPATH), an international professional and advocacy body, and the Endocrine Society. Both have been criticised (see WPATH Files and Endocrine Society).

The picture has changed fast since 2023:

• State bans. As of May 2026, 27 states had laws or policies restricting medical transition for minors (Newsweek, citing KFF). In United States v. Skrmetti (June 2025), the Supreme Court upheld Tennessee's ban by 6–3 (KFF). Other states, mostly on the West Coast and in the Northeast, have "shield laws" protecting access.
• Federal action. The Department of Health and Human Services (HHS) published an evidence review in May 2025, and a peer-reviewed final version in November 2025 (HHS). A federal rule ending Medicaid and CHIP (the Children's Health Insurance Program) funding for these treatments in minors took effect on 13 October 2026 (AJMC). A separate rule that would bar Medicare-participating hospitals from providing them has been proposed (Regulations.gov).
• Clinic closures. Several hospital programmes have closed. The largest, at Children's Hospital Los Angeles, shut in July 2025 (LA Times).

In practice, US families may meet very different services: a hospital clinic with a team, a private therapist who writes "letters of support", a paediatrician who refers to an endocrinologist, or an adult-oriented informed-consent clinic once a child turns 18 (see below). Several US programmes are discussed on Scandals, including Texas Children's Hospital and the Washington University Transgender Center. For the law, see United States.

Nordic countries

The Nordic countries were early adopters of youth transition and were among the first to pull back:

• Finland (2020). The Council for Choices in Health Care (COHERE) made psychosocial support and psychotherapy the first-line treatment and largely limited hormones to young people with early-childhood-onset dysphoria and no serious co-occurring conditions (COHERE 2020, unofficial translation).
• Sweden (2022). The National Board of Health and Welfare judged that for adolescents as a group, the risks of blockers and hormones "are likely to outweigh the expected benefits", and limited them to exceptional cases (SEGM summary; see also Karolinska).
• Norway (2023). The Norwegian Healthcare Investigation Board (UKOM) described these treatments for minors as experimental (Gender Clinic News).

Nordic services usually involve long, team-based assessment. A Norwegian study of all 1,258 under-18s referred to the national centre from 2000 to 2020 found that 22% of those seen were discharged without medical treatment. Of those who started puberty blockers, 97% went on to cross-sex hormones (Nyquist et al. 2025, retracted 2026). Parents should know that once a child starts blockers, continuing to hormones has been the usual path.

Australia and New Zealand

• Australia. Queensland paused puberty blockers and hormones for new patients in its public system in January 2025. In December 2025 it extended the pause until the UK trial reports (expected 2031), even though the review it had commissioned, by former Victorian chief psychiatrist Ruth Vine, did not recommend a blanket ban (Guardian 2025). The Northern Territory followed. The National Health and Medical Research Council (NHMRC) is writing national guidelines, with interim advice on puberty suppression due for consultation in mid-2026 (NHMRC). See Australia.
• New Zealand. From 19 December 2025, doctors can no longer start puberty blockers for gender dysphoria in new patients. Existing patients can continue. The government said the restriction will stay until the UK trial reports (RNZ 2025).

Show details: summary table (as of October 2026)

Country	Puberty blockers (new patients)	Cross-sex hormones under 18	Typical model
England	Research trial only	New prescriptions paused (March 2026)	Regional children's hospital teams; long waits
United States	Banned or restricted in 27 states; available in others	Same	Varies: hospital clinics, private therapists, informed-consent clinics for adults
Finland, Sweden, Norway	Restricted to exceptional cases or research	Restricted	Extended multidisciplinary assessment; psychotherapy first
Queensland, Northern Territory	Paused in public system	Paused in public system	National guidelines in development
New Zealand	No new prescriptions	Not restricted by the 2025 rule	Precautionary pending UK trial

Two models: assessment and informed consent

It helps to know which kind of service you are dealing with. Broadly, there are two models.

Assessment model. A team, usually including psychologists or psychiatrists, takes time to understand the young person before any medical step. That means their history, family, sexuality, mental health, possible autism and any trauma. A good assessment treats gender distress as something to understand, not a diagnosis to confirm. Clinicians who worked at GIDS described young people who, during extended assessment, came to understand their distress differently and no longer wanted medical treatment (Churcher Clarke & Spiliadis 2019). This approach has since grown into what is called gender-exploratory therapy.

Informed-consent model. The patient states their gender identity, a clinician explains the effects and risks, the patient signs a consent form, and hormones are prescribed, often without any mental health assessment or letter. Supporters see this as respecting adults' autonomy and removing "gatekeeping". It is mostly used with adults, but families meet it when a child turns 18, or through online providers. Critics, including some detransitioners, say a consent form is not the same as being informed. Real informed consent includes the alternatives, including no treatment, and a check that the patient understands and is free from pressure (CAN-SG, a gender-critical clinicians' group). That argument is covered on Informed Consent Critique.

Many services sit in between. A "gender-affirming" clinic may hold an assessment that assumes, from the first appointment, that medical transition is the goal. The bioethicist Moti Gorin has noted a shift in the US: some now justify youth transition by the patient's "embodiment goals" rather than proven mental health benefit. He argues this misunderstands the role of autonomy in medicine (Gorin 2024). For parents, the practical question is whether the clinicians are trying to understand your child or only to process them.

What families and detransitioners report

The accounts below come from Reddit's r/detrans (where only detransitioners and desisters may post, though anyone can comment) and are self-selected. They show patterns worth knowing about, not how often things happen. Surveys back up some of the themes. In a survey of 100 detransitioners, 55% felt they had not been adequately evaluated before transitioning (Littman 2021). In an online survey of 237 detransitioners, 70% said they came to see their dysphoria as linked to other issues (Vandenbussche 2022).

Among 3,094 r/detrans stories analysed for this site, 936 described dissatisfaction with the healthcare system, and 244 were judged to describe parental, therapeutic or medical pressure as a significant factor in their transition. These are self-selected posts with features extracted by AI, so the figures are not rates (detrans.ai stats).

Speed

A recurring complaint is speed: a diagnosis or prescription after one short visit.

It was insane how fast I got put on T. Only took 1 appointment. If I had even just a month of therapy I guarantee I never would’ve taken it in the first place —RequirementSimple580, detrans female

A parent described the same pattern:

Our son received hormones after once visit to a trans clinic. No clinical history requested, no psyche referral, just affirmation and cross sex hormones. —Criticalmode3, parent

Some recall being told about the effects they wanted, but not the risks:

They read me the side-effects of testosterone, all of which I knew and was exactly why I wanted the drug in the first place (body hair growth, fat redistribution, enlarged larynx, etc.), but absolutely nothing about the health risks. —sirmooseking, fuck gender

Co-occurring conditions overlooked

Young people referred to gender services have far more mental health problems than their peers. In Finland, 45.7% of gender-referred young people had needed specialist psychiatric care before referral, against 15.0% of matched controls (Ruuska et al. 2026). In English primary care records, 52.7% of young people with a gender dysphoria record also had anxiety, depression or self-harm recorded (Jarvis et al. 2025). The Cass Review recommended that every young person be screened for autism and other conditions (Cass 2024). See Mental Health, Autism and Trauma.

Detransitioners often describe these issues being noted and then set aside:

I was so worried that they would be concerned about the fact that I was literally testifying in court against someone who raped me, had an eating disorder, had a history of depression and suicide attempts, had severe lifelong anxiety and panic attacks but they weren’t concerned about these things at all. —Admirable_Treacle_97, detrans female

When I mentioned the word “trauma” at the gender clinic, I was told “aaaand you can talk to someone else about that.” In exactly that manner. No referral given, just a prescription for testosterone. —evergone3

Some describe clinicians who seemed afraid to ask questions. One desister compared how his doctor handled a trans identity with how they handled ADHD:

When I told my doctor I was trans, I saw a sudden fear come over them. They were very careful not to question it. They referred me to the gender clinic immediately. —tophology, desisted male

Another recalled a therapist admitting to that pressure:

Basically he told me he is pressured to not question teens about their choice to transition cuz that would be labelled as transphobic by his peers. —AbsolRiatun, medically desisted

"Would you rather...": the suicide framing

One warning sign families describe again and again is being told, in effect, that the choice is transition or suicide, sometimes in the words "would you rather have a living son or a dead daughter?"

My parents did not support it. They were talked into it and basically forced to support it by being told that I will commit suicide, it's better to have an alive son than a dead daughter. They were treated like bigoted assholes until they gave in. —throwawayeffoff, detrans female

I was in the room when my endocrinologist said to my parents “would you rather an alive daughter or dead son.” It’s such a dangerous statement, especially in front of the child. —Even_Discipline_7474, Socially Trans - Regrets entire Transition

One detransitioned man described what this did to his family. His father became convinced he was at risk, and his mother's only session with a psychologist went badly:

She was hoping the psychologist would help her deal with my decision to transition but instead he just bullied her for not immediately accepting it right off the bat. —Hedera_Thorn, detrans male

This sort of rhetoric completely weaponises the care and love that parents have for their children. —Hedera_Thorn, detrans male

Suicidal feelings in a child must always be taken seriously. But the claim that medical transition is the proven way to prevent suicide is not supported by the evidence. The Cass Review found no good evidence that gender-affirming treatment reduces suicide risk (Cass 2024). A Finnish register study found that the higher suicide rate among gender-referred young people was explained mainly by their psychiatric problems, not by whether they had medical transition (Ruuska et al. 2024). The full evidence is on Suicide and Transition. A clinician who presents transition as the only alternative to death is giving you a reason to be more careful, not less.

A clinical psychologist whose child later desisted described testing this claim:

When the quack “gender therapist” my kid had connected with tried to push transition or suicide with me, I asked her to show me the longitudinal studies. She said she’d send links. Crickets. Then I asked her to explain to me how she was trained to assess for and treat suicidality. Again, crickets. —PatchkaKnits, verified professional and parent

When parents slowed things down

Not every account is negative. Some young people credit a parent, or a careful clinic, with giving them time.

after a 3 hour session, the therapist wanted to book an appointment with the endocrinologist to see what my options were to get on HRT. My mom shut that down and found me a therapist to help me with my anxiety. —Ok-Many-4140, Socially Trans - Regrets entire Transition

My diagnostic process took 7 years and I'm so glad that I had to wait for such a long time so I couldn't get my diagnosis earlier and therefore any hormones. —chinchillade, desisted female

One desister described a gender clinic that took her possible autism seriously:

I decided to be honest with the clinic and told them i'd been suspected for some time, they got me a screening test and I scored pretty high (41/50), high enough that they pulled some strings and got be boosted to the top of the waiting list for assessment. —JazziestCabbage, desisted female

The common thread is time and curiosity: clinicians who looked at the whole person and treated waiting as safe rather than dangerous.

Questions parents can ask clinicians

You are entitled to ask questions, and a good clinician will welcome them. Write them down, take notes, and bring another adult if you can. Possible questions:

About the evidence

• What is the quality of the evidence for this treatment in young people like my child? Have you read the systematic reviews (for example the University of York reviews for the Cass Review, or Miroshnychenko et al. 2025, which rated the evidence for puberty blockers as mostly "very low certainty")?
• What outcome data does your own clinic collect? How many patients do you follow up after five or ten years, and how many have you lost contact with?
• How many of your patients have stopped treatment or detransitioned, and how would you know?

About assessment and alternatives

• How long will the assessment take, and who does it?
• Will you assess for autism, ADHD, depression, anxiety, eating disorders, trauma and other conditions? What happens if you find them?
• What are the alternatives to medical treatment, including psychological support, family therapy and simply waiting? What happens to young people who take those routes? Older studies found that most children with gender dysphoria who were not medically treated stopped feeling it by adulthood (Steensma et al. 2013; Singh et al. 2021). Ask how that applies to your child.
• Has my child's sexual orientation been discussed? Some detransitioners describe transition as a way of avoiding being gay (see Internalised Homophobia).

About effects

• What does this treatment do to fertility? Is fertility preservation possible at my child's stage of puberty, and what does it involve? (See Fertility.)
• What are the effects on sexual function and the ability to orgasm, especially if puberty is blocked early? (See Sexual Function.)
• What are the effects on bones, brain development and height? Which changes are permanent?

About the future

• What happens if my child changes their mind? Will you support stopping, and do you have experience with detransition?
• At what point do you expect to move from one step to the next, and who decides?

About the clinicians

• What is your training in assessing gender-distressed young people and treating suicidality?
• Do you have any financial or professional conflicts of interest, such as industry funding, membership of advocacy bodies, or income from specific treatments?
• Will you share your notes and letters with us?

A clinician who cannot answer these, who becomes defensive, or who suggests that asking them is transphobic, is telling you something important.

Detransitioners often say they wish they had been told plainly about some of these effects. One young woman questioning her own identity wrote:

I wanted puberty blockers when I was younger because I heard they were harmless and would help people struggling with their self-image like me. I was never told about any sort of biological damage they could cause. —willow_wind, Questioning own transgender status

Second opinions

Getting a second opinion is normal in medicine, and nothing in gender care should make it less so. Practical points:

• Look for breadth. A general child and adolescent psychiatrist, a clinical psychologist or a family therapist may give a wider view than a second gender specialist. Some parents deliberately choose a therapist who is not a gender specialist.
• Explore without labels. A therapist who explores your child's feelings without starting from a conclusion either way is different from one who sets out to confirm or to change an identity. The support directory lists gender-exploratory therapists and support groups.
• Bring the history. Bring school reports, earlier assessments and a timeline of when the distress began and what else was going on, such as bullying, puberty, friendships, online life or family stress.
• Watch for pressure to hurry. If a clinic urges you to decide before a second opinion, ask why. Very few situations in this area need a decision within weeks.

Some detransitioners say a single dissenting professional, or a parent's doubts, made the difference. Others say they ignored that voice and wish they hadn't. See Gender-Exploratory Therapy.

Consent and capacity for minors

United Kingdom: Gillick and Bell v Tavistock

In England and Wales, 16- and 17-year-olds are presumed able to consent to their own treatment. Under-16s can consent if they are Gillick competent, meaning they understand enough about what the treatment involves. Otherwise a person with parental responsibility consents for them (NHS).

In 2020, the detransitioner Keira Bell and a parent ("Mrs A") challenged GIDS. The High Court said it was highly unlikely that under-16s could be competent to consent to puberty blockers, given their long-term consequences. In 2021 the Court of Appeal overturned that decision, ruling that capacity was for clinicians, not courts, to judge (Weightmans). See Keira Bell v Tavistock. Today blockers and hormones are mostly unavailable to new NHS patients under 18 in any case. The PATHWAYS trial requires parental consent, a diagnosis held for at least two years, and approval by a multidisciplinary team (Hansard 2026).

United States

US rules depend on the state. In general, parents must consent to medical treatment for minors. In states with bans, the treatments are prohibited for under-18s whatever the parents want. In shield-law states, they remain available with parental consent. Some states let minors consent alone to certain kinds of care, such as mental health counselling, from a set age. This can mean a teenager sees a therapist without parents being involved. Families should check their own state's rules, which have been changing quickly.

Lawsuits brought by detransitioners in the US often turn on whether patients and parents were properly informed. See Lawsuits, including Chloe Cole v Kaiser.

Records and parental access

Clinical notes matter. Families often learn more from the written record than from appointments, and a detransitioner may later need these records for their own care or for a legal claim.

• United States. Under HIPAA (the federal health privacy law), a parent is usually treated as the minor's "personal representative" and can see their records. There are exceptions where state law lets the minor consent to a service, and HIPAA defers to state law on these points (HHS). Many patient portals limit parents' access once a child reaches a certain age.
• United Kingdom. Under data protection law, the right to see health records belongs to the child. A parent with parental responsibility can make a request on the child's behalf when the child cannot exercise the right themselves. Once a child is mature enough, their wishes generally decide the matter (ICO).

Practical steps: ask for copies of all letters, including letters to GPs, surgeons and schools. Ask for corrections if the notes are wrong. Keep your own dated notes of what was said at each appointment. Some detransitioners describe finding things in their records that they had not been told:

I then reviewed my medical records and googled my doctor; I discovered my doctor was lying in notes about our interactions, lying to other doctors about my medical history… —jadepraerie, detransational

Another found that her surgery referral letter, written after three sessions, contained "strange rambling" rather than a real assessment (phantomofthedennys, detrans female).

If your child changes their mind

Ask before treatment starts how the clinic handles patients who stop. Some detransitioners report that the clinic that started their transition was poorly equipped to help them stop, or lost interest:

In the letter, it states that I no longer wanted to take hormones or have surgery, and said (not suggested or implied, but said) that they did not believe I was 'mentally stable' as I did not want to continue transitioning. —Daxmunro, detrans female

quite a bit of us have reached out to our gender therapists as well as endocrinologists who prescribed us HRT only to find out they closed our medical files and will not update them with the fact we medically detransitioned. —DetransIS, Detrans Female with a CCSD

This is one reason detransition is so poorly counted. Clinics rarely record it, and patients who stop often simply stop attending (Cohn 2023). In the Norwegian cohort, the authors said their own detransition figure was probably an underestimate because of loss to follow-up (Nyquist et al. 2025, retracted 2026). Other people did not regret being able to change course. One desisted woman recalled a therapist in 2013 who made her wait and address her mental health first, and wrote that she was "so grateful" (meteorpuppy, desisted female). For what comes next, see Supporting a Detransitioning Child and Detransition Healthcare.

Trans perspectives on clinics

Trans-identified commenters often see the same clinics very differently. For them, long waits and assessment are obstacles. In trans forums, people in the UK describe waiting years for an adult clinic:

i was referred the month before i turned 17 and its taken me just under 4 years on the waitlist to get hrt —Aiden1975, ftm

A Swedish commenter described the assessment there:

Once you get to the gender clinic you’ll spend a minimum of 12 months, often two years, talking to a psychiatrist and a psychologist about your gender identity, relationship with your body, sex life and what toys you played with as a child. —armadillotangerine, ftm

Others resent mental health letters as a demand that they "validate" themselves within a system they distrust (heyoceans, ftm). In the same threads, some commenters recommend private providers or self-sourced, black-market hormones when NHS waits are long (see DIY Hormones). One commenter, replying to someone frustrated by a therapist, suggested that patients often tell clinicians they already have it "all figured out" (Alice_Oe, mtf).

Parents should understand both points. For a young person who is sure, assessment can feel like being disbelieved, and that frustration is real. But a young person may also have learned online what to say to a clinic, so a confident account at the first appointment is not the same as a full picture. The waits that frustrate some trans patients are the same time in which, in the accounts above, some young people came to understand themselves differently.

Warning signs reported by families

Drawing the accounts together, these are the recurring warning signs in the accounts of families and detransitioners:

• Speed: a diagnosis or prescription after one or two short appointments, or pressure to decide quickly.
• No real history: little interest in mental health, autism, trauma, eating disorders, sexuality or family circumstances, or noting these and then moving on.
• The suicide ultimatum: "would you rather have a dead daughter or a living son?", or any framing that makes transition the only alternative to death.
• Treating doubt as bigotry: parents' questions described as transphobia, or parents pushed out of decisions.
• One-sided information: the desired effects explained, but not fertility, sexual function, bone health or the weakness of the evidence.
• No exit plan: no clear answer about what happens if the young person changes their mind.
• Defensiveness about evidence: inability or unwillingness to discuss systematic reviews, outcome data or the changes in other countries.

None of these proves a clinic is acting in bad faith. Together, they suggest a service that may not be looking at the whole child.

Limitations

This page relies on self-selected Reddit accounts, a few surveys of detransitioners and news reporting of fast-changing policy. The accounts describe experiences across many years and countries, some from services that no longer exist. People who are satisfied with their clinics are less likely to post in detransition forums. Policy details, especially in the US, the UK and Australia, may have changed since October 2026. Check current rules with your own health service.

References

• Alder Hey Children's NHS Foundation Trust (2024). New Specialist Gender Service for Children and Young People opens. source.
• AJMC (2026). CMS Rule Ends Medicaid, CHIP Funding for Pediatric Gender Care. source.
• BBC News (2025). Streeting rejects calls to stop puberty blocker trial. source.
• BBC News (2026). NHS England pauses new prescriptions of cross-sex hormones for under-18s. source.
• BMJ (2025). "Unacceptable" waits and lack of safety data at adult gender clinics in England, review finds. source.
• CAN-SG (Clinical Advisory Network on Sex and Gender; gender-critical clinicians' group) (2022). What is the informed consent model in gender care? source.
• Cass, H. (2024). Independent review of gender identity services for children and young people: Final report. study page, source.
• Churcher Clarke, A., & Spiliadis, A. (2019). Taking the lid off the box: The value of extended clinical assessment for adolescents presenting with gender identity difficulties. Clinical Child Psychology and Psychiatry. study page, source.
• Cohn, J. (2023). The Detransition Rate Is Unknown. study page.
• COHERE Finland (2020). Medical Treatment Methods for Dysphoria Related to Gender Variance in Minors (unofficial translation hosted by SEGM). source.
• Gender Clinic News (Bernard Lane) (2023). 'Yes, it's an experiment'. source.
• Gorin, M. (2024). What Is the Aim of Pediatric "Gender-Affirming" Care? study page, source.
• The Guardian (2025). Queensland ban on puberty blockers for gender dysphoria to continue until at least 2031. source.
• Hansard, House of Lords (2026). Puberty Blockers Trial: Consent, 25 June 2026. source.
• HHS (2025). Treatment for Pediatric Gender Dysphoria: Review of Evidence and Best Practices. source.
• HHS. Personal Representatives and Minors (HIPAA FAQ). source.
• Information Commissioner's Office (2026). How do we recognise a subject access request (SAR)? source.
• The Independent (2025). Children waiting two years for critical gender care as numbers trapped on waiting lists soar. source.
• The Independent (2026). High Court dismisses legal bid to stop puberty blocker trial for children. source.
• Jarvis et al. (2025). Epidemiology of gender dysphoria and gender incongruence in children and young people attending primary care practices in England: retrospective cohort study. study page, source.
• KFF (2025). What are the Implications of the Skrmetti Ruling for Minors' Access to Gender Affirming Care? source.
• Littman, L. (2021). Individuals Treated for Gender Dysphoria with Medical and/or Surgical Transition Who Subsequently Detransitioned: A Survey of 100 Detransitioners. Archives of Sexual Behavior. study page, source.
• Los Angeles Times (2025). Children's Hospital L.A. ends transgender program despite state law. source.
• Miroshnychenko, A., et al. (2025). Puberty blockers for gender dysphoria in youth: A systematic review and meta-analysis. study page, source.
• Newsweek (2026). Map Shows States Protecting Gender-Affirming Care After Trump's Medicaid Funding Cut (citing the KFF policy tracker). source.
• NHMRC. Guideline development process for the care of trans and gender diverse people under 18 with gender dysphoria. source.
• NHS. Children and young people: Consent to treatment. source.
• Nyquist, C. B., et al. (2025). Treatment trajectories among children and adolescents referred to the Norwegian National Center for Gender Incongruence. study page, source.
• Regulations.gov (2025). Hospital Condition of Participation: Prohibiting Sex-Rejecting Procedures for Children (proposed rule, CMS-2025-1822). source.
• RNZ (2025). New Zealand pushes pause on puberty blockers pending UK trial. source.
• Ruuska, S.-M., Tuisku, K., Holttinen, T., & Kaltiala, R. (2024). All-cause and suicide mortalities among adolescents and young adults who contacted specialised gender identity services in Finland in 1996–2019: a register study. BMJ Mental Health. source.
• Ruuska et al. (2026). Psychiatric Morbidity Among Adolescents and Young Adults Who Contacted Specialised Gender Identity Services in Finland. Acta Paediatrica. study page, source.
• SEGM (Society for Evidence-Based Gender Medicine; advocates a cautious approach). Swedish Transgender Treatment Guidelines for Youth. source.
• Singh, D., Bradley, S. J., & Zucker, K. J. (2021). A Follow-Up Study of Boys With Gender Identity Disorder. Frontiers in Psychiatry. study page.
• Steensma, T. D., et al. (2013). Factors associated with desistence and persistence of childhood gender dysphoria: a quantitative follow-up study. study page.
• Vandenbussche, E. (2022). Detransition-Related Needs and Support: A Cross-Sectional Online Survey. Journal of Homosexuality. study page, source.
• Weightmans (2021). Parenting decisions and gender dysphoria: what is the impact of the Court of Appeal decision in Bell/Tavistock? source.